Engineers Gate Manager’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-69,100
Closed -$1.14M 2203
2021
Q1
$1.14M Buy
69,100
+34,740
+101% +$791K 0.06% 530
2020
Q4
$633K Sell
34,360
-37,750
-52% -$676K 0.03% 836
2020
Q3
$981K Buy
72,110
+59,200
+459% +$913K 0.05% 622
2020
Q2
$231K Buy
+12,910
New +$195K 0.01% 1372
2020
Q1
Sell
-17,800
Closed -$145K 2071
2019
Q4
$145K Buy
+17,800
New +$164K 0.01% 1517

Other funds holding TBIO

Engineers Gate Manager's TBIO Position: Q2 2021 in Review

Engineers Gate Manager sold out of Translate Bio, Inc. Common Stock (TBIO) in Q2 2021, closing a stake of 69,100 shares — an estimated $1.14M sold.

Engineers Gate Manager first reported a position in TBIO in Q4 2019 and held it in 5 quarters. The position peaked at $1.14M in Q1 2021. 145 funds tracked by Wall St. Rank hold TBIO as of Q2 2021.

  • Engineers Gate Manager reported no remaining Translate Bio, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Engineers Gate Manager sold 69,100 Translate Bio, Inc. Common Stock shares in Q2 2021, an estimated $1.14M.
  • Engineers Gate Manager first reported a position in Translate Bio, Inc. Common Stock in Q4 2019 and held it in 5 quarters.
  • Engineers Gate Manager's Translate Bio, Inc. Common Stock position peaked at $1.14M in Q1 2021.
  • 145 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q2 2021.

Based on Engineers Gate Manager's 13F filing for Q2 2021, filed 16 Aug 2021.